Abstract
The criteria for heart transplantation are evolving, and higher-risk patients are being transplanted with reasonable outcomes. Previously established contraindications may be less absolute and more flexible than initially proposed. When assessing whether a certain patient-related factor is prohibitive, the stagnant donor pool should be taken into consideration. We must remain an advocate for the individual patient while factoring in the ethical dimension of organ supply and demand. The current trend of using marginal donors for higher-risk patients solves part of this ethical dilemma. As such, the contraindications discussed must be viewed in this broader context and may at times be dynamic.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aguero F, Castel MA, Cocchi S et al (2016) An update on heart transplantation in human immunodeficiency virus-infected patients. Am J Transplant 16(1):21–28. https://doi.org/10.1111/ajt.13496
Belga S, Doucette KE (2016) Hepatitis C in non-hepatic solid organ transplant candidates and recipients: a new horizon. World J Gastroenterol 22(4):1650–1663. https://doi.org/10.3748/wjg.v22.i4.1650
Botha P, Peaston R, White K et al (2008) Smoking after cardiac transplantation. Am J Transplant 8(4):866–871. https://doi.org/10.1111/j.1600-6143.2007.02119.x
Califf RM, Adams KF, McKenna WJ et al (1997) A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST). Am Heart J 134(1):44–54. S0002-8703(97)70105-4 [pii]
Cannon RM, Hughes MG, Jones CM et al (2012) A review of the United States experience with combined heart-liver transplantation. Transpl Int 25(12):1223–1228. https://doi.org/10.1111/j.1432-2277.2012.01551.x
Clerkin KJ, Naka Y, Mancini DM et al (2016) The impact of obesity on patients bridged to transplantation with continuous-flow left ventricular assist devices. JACC Heart Fail 4(10):761–768. https://doi.org/10.1016/j.jchf.2016.05.010
Daneshvar D, Czer LS, Phan A et al (2011) Heart transplantation in patients aged 70 years and older: a two-decade experience. Transplant Proc 43(10):3851–3856. https://doi.org/10.1016/j.transproceed.2011.08.086
Davis MK, Kale P, Liedtke M et al (2015) Outcomes after heart transplantation for amyloid cardiomyopathy in the modern era. Am J Transplant 15(3):650–658. https://doi.org/10.1111/ajt.13025
Geissler EK (2015) Skin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer. Transp Res 4:1.. eCollection 2015. https://doi.org/10.1186/s13737-014-0022-4
Goldstein DJ, Bello R, Shin JJ et al (2012) Outcomes of cardiac transplantation in septuagenarians. J Heart Lung Transplant 31(7):679–685. https://doi.org/10.1016/j.healun.2012.03.019
Healy AH, Baird BC, Drakos SG et al (2013) Impact of ventricular assist device complications on posttransplant survival: an analysis of the United network of organ sharing database. Ann Thorac Surg 95(3):870–875. https://doi.org/10.1016/j.athoracsur.2012.10.080
Jimenez Mazuecos JM, Fuentes Manso R, Segovia Cubero J et al (2003) Is heart transplantation for primary cardiac sarcoma a useful therapeutic option? Rev Esp Cardiol 56(4):408–411. 13045658 [pii]
LaRue SJ, Garcia-Cortes R, Nassif ME et al (2015) Treatment of secondary pulmonary hypertension with bosentan after left ventricular assist device implantation. Cardiovasc Ther 33(2):50–55. https://doi.org/10.1111/1755-5922.12111
Lin MH, Chou NK, Chi NH et al (2012) The outcome of heart transplantation in hepatitis C-positive recipients. Transplant Proc 44(4):890–893. https://doi.org/10.1016/j.transproceed.2012.03.024
Macha M, Molina EJ, Franco M et al (2009) Pre-transplant obesity in heart transplantation: are there predictors of worse outcomes? Scand Cardiovasc J 43(5):304–310. https://doi.org/10.1080/14017430902810911
Maldonado JR, Dubois HC, David EE et al (2012) The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT): a new tool for the psychosocial evaluation of pre-transplant candidates. Psychosomatics 53(2):123–132. https://doi.org/10.1016/j.psym.2011.12.012
Mehra MR, Canter CE, Hannan MM et al (2016) The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transplant 35(1):1–23. https://doi.org/10.1016/j.healun.2015.10.023
Mikus E, Stepanenko A, Krabatsch T et al (2011) Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients. Eur J Cardiothorac Surg 40(4):971–977. https://doi.org/10.1016/j.ejcts.2011.01.019
Patlolla V, Mogulla V, DeNofrio D et al (2011) Outcomes in patients with symptomatic cerebrovascular disease undergoing heart transplantation. J Am Coll Cardiol 58(10):1036–1041. https://doi.org/10.1016/j.jacc.2011.04.038
Perkel D, Czer LS, Morrissey RP et al (2013) Heart transplantation for end-stage heart failure due to cardiac sarcoidosis. Transplant Proc 45(6):2384–2386. https://doi.org/10.1016/j.transproceed.2013.02.116
Russo MJ, Chen JM, Hong KN et al (2006) Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: an analysis of the United Network of Organ Sharing database. Circulation 114(21):2280–2287. CIRCULATIONAHA.106.615708 [pii]
Russo MJ, Hong KN, Davies RR et al (2010) The effect of body mass index on survival following heart transplantation: do outcomes support consensus guidelines? Ann Surg 251(1):144–152. https://doi.org/10.1097/SLA.0b013e3181b5db3c
Ruzza A, Czer LS, Trento A et al (2013) Combined heart and kidney transplantation: what is the appropriate surgical sequence? Interact Cardiovasc Thorac Surg 17(2):416–418. https://doi.org/10.1093/icvts/ivt172
Salzberg SP, Lachat ML, von Harbou K et al (2005) Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates. Eur J Cardiothorac Surg 27(2):222–225. S1010-7940(04)00838-3 [pii]
Sanchez-Lazaro IJ, Almenar L, Martinez-Dolz L et al (2007) Impact of smoking on survival after heart transplantation. Transplant Proc 39(7):2377–2378. S0041-1345(07)00783-X [pii]
Schulman AR, Martens TP, Russo MJ et al (2009) Effect of left ventricular assist device infection on post-transplant outcomes. J Heart Lung Transplant 28(3):237–242. https://doi.org/10.1016/j.healun.2008.12.007
Shah SK, Gregoric ID, Nathan SS et al (2015) Simultaneous left ventricular assist device placement and laparoscopic sleeve gastrectomy as a bridge to transplant for morbidly obese patients with severe heart failure. J Heart Lung Transplant 34(11):1489–1491. https://doi.org/10.1016/j.healun.2015.06.011
Silva Enciso J, Kato TS, Jin Z et al (2014) Effect of peripheral vascular disease on mortality in cardiac transplant recipients (from the United Network of Organ Sharing Database). Am J Cardiol 114(7):1111–1115. https://doi.org/10.1016/j.amjcard.2014.07.027
Sinha P, Chen JM, Flannery M et al (2000) Infections during left ventricular assist device support do not affect posttransplant outcomes. Circulation 102(19 Suppl 3):III194–III199
Sperry BW, Ikram A, Hachamovitch R et al (2016) Efficacy of chemotherapy for light-chain amyloidosis in patients presenting with symptomatic heart failure. J Am Coll Cardiol 67(25):2941–2948. https://doi.org/10.1016/j.jacc.2016.03.593
Tedford RJ, Hemnes AR, Russell SD et al (2008) PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail 1(4):213–219. https://doi.org/10.1161/CIRCHEARTFAILURE.108.796789
Tong MZ, Smedira NG, Soltesz EG et al (2015) Outcomes of heart transplant after left ventricular assist device specific and related infection. Ann Thorac Surg 100(4):1292–1297. https://doi.org/10.1016/j.athoracsur.2015.04.047
Torre-Amione G, Southard RE, Loebe MM et al (2010) Reversal of secondary pulmonary hypertension by axial and pulsatile mechanical circulatory support. J Heart Lung Transplant 29(2):195–200. https://doi.org/10.1016/j.healun.2009.05.030
Uberfuhr P, Meiser B, Fuchs A et al (2002) Heart transplantation: an approach to treating primary cardiac sarcoma? J Heart Lung Transplant 21(10):1135–1139. S1053249802004096 [pii]
Zaidi AR, Zaidi A, Vaitkus PT (2007) Outcome of heart transplantation in patients with sarcoid cardiomyopathy. J Heart Lung Transplant 26(7):714–717. S1053-2498(07)00369-5 [pii]
Zimpfer D, Zrunek P, Roethy W et al (2007) Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. J Thorac Cardiovasc Surg 133(3):689–695. S0022-5223(06)02098-8 [pii]
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Hawwa, N., Taylor, D.O. (2020). Contraindications to Heart Transplantation. In: Bogar, L., Stempien-Otero, A. (eds) Contemporary Heart Transplantation. Organ and Tissue Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-58054-8_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-58054-8_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-58053-1
Online ISBN: 978-3-319-58054-8
eBook Packages: MedicineReference Module Medicine